Cipher Pharmaceuticals Statistics
Total Valuation
TSX:CPH has a market cap or net worth of CAD 319.87 million. The enterprise value is 362.06 million.
Market Cap | 319.87M |
Enterprise Value | 362.06M |
Important Dates
The next estimated earnings date is Friday, March 14, 2025.
Earnings Date | Mar 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TSX:CPH has 25.59 million shares outstanding. The number of shares has decreased by -2.82% in one year.
Current Share Class | n/a |
Shares Outstanding | 25.59M |
Shares Change (YoY) | -2.82% |
Shares Change (QoQ) | +4.58% |
Owned by Insiders (%) | 42.03% |
Owned by Institutions (%) | 1.43% |
Float | 14.83M |
Valuation Ratios
The trailing PE ratio is 14.63 and the forward PE ratio is 13.91.
PE Ratio | 14.63 |
Forward PE | 13.91 |
PS Ratio | 8.53 |
PB Ratio | 2.40 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.17, with an EV/FCF ratio of -4.00.
EV / Earnings | 16.90 |
EV / Sales | 10.13 |
EV / EBITDA | 21.17 |
EV / EBIT | 27.12 |
EV / FCF | -4.00 |
Financial Position
The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.41.
Current Ratio | 2.00 |
Quick Ratio | 1.57 |
Debt / Equity | 0.41 |
Debt / EBITDA | 3.22 |
Debt / FCF | -0.61 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 17.98% and return on invested capital (ROIC) is 5.68%.
Return on Equity (ROE) | 17.98% |
Return on Assets (ROA) | 5.06% |
Return on Invested Capital (ROIC) | 5.68% |
Return on Capital Employed (ROCE) | 7.09% |
Revenue Per Employee | 7.15M |
Profits Per Employee | 4.28M |
Employee Count | 5 |
Asset Turnover | 0.22 |
Inventory Turnover | 1.30 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +68.01% in the last 52 weeks. The beta is 1.18, so TSX:CPH's price volatility has been higher than the market average.
Beta (5Y) | 1.18 |
52-Week Price Change | +68.01% |
50-Day Moving Average | 13.90 |
200-Day Moving Average | 13.08 |
Relative Strength Index (RSI) | 30.01 |
Average Volume (20 Days) | 39,821 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSX:CPH had revenue of CAD 35.75 million and earned 21.42 million in profits. Earnings per share was 0.85.
Revenue | 35.75M |
Gross Profit | 28.88M |
Operating Income | 13.35M |
Pretax Income | 12.82M |
Net Income | 21.42M |
EBITDA | 16.99M |
EBIT | 13.35M |
Earnings Per Share (EPS) | 0.85 |
Balance Sheet
The company has 12.87 million in cash and 55.05 million in debt, giving a net cash position of -42.19 million or -1.65 per share.
Cash & Cash Equivalents | 12.87M |
Total Debt | 55.05M |
Net Cash | -42.19M |
Net Cash Per Share | -1.65 |
Equity (Book Value) | 133.55M |
Book Value Per Share | 5.22 |
Working Capital | 19.66M |
Cash Flow
In the last 12 months, operating cash flow was 17.67 million and capital expenditures -108.15 million, giving a free cash flow of -90.49 million.
Operating Cash Flow | 17.67M |
Capital Expenditures | -108.15M |
Free Cash Flow | -90.49M |
FCF Per Share | -3.54 |
Margins
Gross margin is 80.78%, with operating and profit margins of 37.35% and 59.92%.
Gross Margin | 80.78% |
Operating Margin | 37.35% |
Pretax Margin | 35.86% |
Profit Margin | 59.92% |
EBITDA Margin | 47.52% |
EBIT Margin | 37.35% |
FCF Margin | n/a |
Dividends & Yields
TSX:CPH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 2.82% |
Shareholder Yield | 2.82% |
Earnings Yield | 6.70% |
FCF Yield | -28.29% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TSX:CPH has an Altman Z-Score of 2.86. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.86 |
Piotroski F-Score | n/a |